Who is the new owner of Hospira?
Others answers (1)
On February 6, 2015 Pfizer became the new owner of Hospira. He acquired Hospira for 17 billion US dollars. Hospira, Inc is a provider of injectable drugs and infusion technologies. The deal is the big opportunity as the deal would push emerging market for biosimilars. Biosimilars are generic drugs seeking to copy expensive and more complex drugs called biologic that until now have largely been immune from competition in the United States. Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, Diabetology/endocrinology, and neurology.
- Show More